Skip to content

Clinical trials

Leukemia, Myeloid, Acute trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Country / region: Netherlands Clear all

91 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20021
20031
20041
20051
20061
20081
20093
20103
20113
20122
20135
20147
20156
20167
20176
20184
20194
20208
20213
20226
20231
20246
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Terminated21
Recruiting14
Active, not recruiting10
Unknown status10
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC11
Novartis Pharmaceuticals7
Stichting Hemato-Oncologie voor Volwassenen Nederland6
Celgene4
Daiichi Sankyo3
Radboud University Medical Center3
AbbVie2
AstraZeneca2
AvenCell Europe GmbH2
Gamida Cell ltd2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute91
Leukemia28
Myelodysplastic Syndromes23
Precursor Cell Lymphoblastic Leukemia-Lymphoma17
Recurrence13
Hematologic Neoplasms11
Neoplasms10
Leukemia, Erythroblastic, Acute8
Leukemia, Megakaryoblastic, Acute8
Leukemia, Monocytic, Acute8

Trials

Showing 76 to 91 of 91. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.